| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 5.850 | 20100301, Scala E
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2011 | Italy | IgE | 1084 | 63.650 | 20110211, DAvino R
| | 1.9 - Pollen Allergy | 2014 | Czech Republic | IgE | 826 | 31.300 | 20140606, Panzner P
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 16.710 | 20120528, Patelis A
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 3.500 | 20120528, Patelis A
| | 4.1.6 - Heterologous Source Sensitized (High IgE) | 2011 | Italy | IgE | 214 | 99.530 | 20110211, DAvino R
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 55.900 | 20140331, Rockmann H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 16.430 | 20130111, Ott H
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.000 | 20130912, Lacerda Araujo LM
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 72.730 | 20110223, De Knop KJ
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 28.130 | 20120528, Patelis A
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 15.630 | 20120528, Patelis A
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 11.620 | 20101214, Gadisseur R
| | 4.1.1 - Heterologous Source Sensitized (Symptoms) | 2013 | Netherlands | IgE | 82 | 92.680 | 20130415, Masthoff LJ
| | 5.1.1 - Source Exposed (Symptoms) | 2013 | Netherlands | IgE | 79 | 79.750 | 20130415, Masthoff LJ
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 35.500 | 20131020, van Rhijn BD
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 14.700 | 20120726, Pedrosa M
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 21.000 | 20140625, Armentia A
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2004 | Germany / Switzerland | IgE (IB) | 65 | 98.500 | | | 4.1.6 - Heterologous Source Sensitized (High IgE) | 2011 | Austria | IgE | 60 | 98.330 | 20110211, DAvino R
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 10.900 | 20120726, Pedrosa M
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 6.000 | 20140625, Armentia A
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Netherlands | IgE | 42 | 80.950 | 20120905, Le TM
| | 1.12 - Oral Allergy Syndrome | 2014 | Belgium | IgE | 38 | 94.740 | 20140718, Faber MA
| | 1.6 - Anaphylaxis, Diagnosed | 2014 | Belgium | IgE | 37 | 37.840 | 20140718, Faber MA
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 62.160 | 20090826, Ebo DG
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 17.140 | 20130605, Simon D
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2014 | Austria | IgE | 35 | 100.000 | 20141020, Guhsl EE
| | 3.2.1 - Source Sensitized (IgE) | 2014 | United States | IgE | 29 | 79.300 | 20140606, Kattan JD
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2004 | Spain | IgE | 26 | 3.800 | | | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 22.730 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Italy | IgE | 21 | 0.000 | 20090808, Krause S
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 50.000 | 20091005, Ott H
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 65.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 20 | 95.000 | 20130401, Berneder M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Belgium | IgE | 20 | 0.000 | 20100628, Verweij MM
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2003 | Denmark / Switzerland | IgE (IB) | 17 | 94.100 | | | 1.1 - Asymptomatic | 2014 | Belgium | IgE | 15 | 93.330 | 20140718, Faber MA
| | 10.1 - Normal Control | 2014 | Belgium | IgE | 15 | 0.000 | 20140718, Faber MA
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | United States | IgE | 13 | 84.600 | 20140606, Kattan JD
|
|
Loading...
Cor a 1
